Advertisement
 
CROs/CMOs
Subscribe to CROs/CMOs

The Lead

AMRI to Acquire Cedarburg Pharmaceuticals for $38.2M

March 24, 2014 2:24 pm | News | Comments

Albany Molecular Research Inc. (AMRI) announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals Inc. for $38.2 million in cash. Read more...              

Charles River to Acquire CRO Services from Galapagos

March 14, 2014 10:22 am | News | Comments

Charles River Laboratories International Inc. announced that it has entered into a definitive...

HHS Establishes New Clinical Study Network

March 12, 2014 3:09 pm | News | Comments

The U.S. Department of Health and Human Services (HHS) established a network of five clinical...

Worldwide Clinical Trials to Use BioClinica’s CTMS for Global Trial Management

March 7, 2014 10:52 am | News | Comments

BioClinica Inc. announced that Worldwide Clinical Trials Inc. has selected BioClinica’s OnPoint...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

ProBioGen and Merus Sign Deal on GlymaxX ADCC Enhancement Technology

March 4, 2014 8:36 am | News | Comments

ProBioGen AG and Merus B.V. signed a non-exclusive commercial option and license agreement on ProBioGen’s GlymaxX fucose-engineering technology. Under the terms of the agreement, ProBioGen is granting Merus the non-exclusive right to use the GlymaxX technology to enhance the ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) activity of one of its lead products, a bispecific anti-cancer antibody.

KCR Strengthens its Footprint in Western Europe

March 4, 2014 8:24 am | News | Comments

European Contract Research Organization (CRO), KCR, which is already operating across 18 countries in Europe as well as the U.S., has recently registered new entities in the UK and Germany. This move is part of the company’s strategy to bring the business closer to Western European customers and further deepen client relationships.

Biopharma Services Launches Full Research Services Platform

February 14, 2014 2:33 pm | News | Comments

Biopharma Services Inc. is pleased to announce that in collaboration with its sister company, ADA Medical Ltd., it can now offer a complete range of contract research services, from early pre-clinical drug development through clinical trials. Read more...

Advertisement

BioClinica Grows eClinical Results in Europe

February 5, 2014 10:42 am | News | Comments

BioClinica Inc. announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology products. Read more...                                 

Ergomed, Ferrer to Co-Develop Insomnia Drug

February 4, 2014 9:45 am | News | Comments

Ergomed Clinical Research Ltd. announces that it has entered into an agreement with Spanish pharmaceutical company Ferrer to support further clinical studies of Lorediplon in patients with insomnia. Read more...          

Datatrak, Clinverse Launch Strategic Partnership

January 21, 2014 12:00 pm | News | Comments

Clinverse Inc., provider of end-to-end technology solutions to automate the financial lifecycle of global clinical trials, announced that it has formed a strategic partnership with Datatrak, which specializes in developing cloud-based, unified eClinical technologies. Read more...

Former Merck Exec Moves to Covance

January 21, 2014 11:53 am | News | Comments

Covance announced that Barry Goldstein has joined its Clinical Development Services business as Vice President and Global Therapeutic Area Head of the expanded Cardiovascular, Metabolic, Endocrine and Renal unit. Read more...       

Par to Acquire JHP Pharmaceuticals

January 21, 2014 11:34 am | News | Comments

Par Pharmaceutical Companies Inc. announced that it has entered into a definitive agreement to acquire JHP Group Holdings, the parent company of JHP Pharmaceuticals, a specialty pharmaceutical company. Read more...           

Advertisement

Reaction Biology, Cisbio Bioassays Sign Distribution Agreement

January 20, 2014 2:35 pm | News | Comments

Reaction Biology Corp. (RBC) announced that it has signed an agreement for Cisbio Bioassays to distribute its epigenetic proteins. This new agreement will give Cisbio worldwide rights to co-market and sell RBC's proteins, used worldwide by researchers in drug discovery. Read more...

Harlan Labs to Open Research Model Facility in India

January 16, 2014 10:35 am | News | Comments

Harlan Laboratories announced the site of its first research model breeding facility in India, located in the Genome Valley Alexandria Technology Park in Hyderabad. Read more...                      

Royal DSM, JLL Create Pharma Services Company

November 19, 2013 10:19 am | News | Comments

JLL Partners (JLL) and Royal DSM  announced the creation of a new company, which will be a global contract development and manufacturing organization (CDMO) for the pharmaceutical industry. So what will this new company offer? Find out...

PRA Acquires CRI Lifetree

November 14, 2013 9:25 am | News | Comments

PRA, a leading clinical research organization (CRO), announced its intent to acquire privately held CRI Lifetree, a specialized research organization. So what will the acquisition of CRI Lifetree enable PRA to provide its clients? Find out...

Alzheimer's Drug Discovery Foundation Expands ACCESS Program

November 6, 2013 2:33 pm | News | Comments

The Alzheimer's Drug Discovery Foundation (ADDF) launched its newly expanded ADDF ACCESS program to provide scientists in academia and small biotechnology companies with access to a virtual network of drug discovery experts and contract research organizations (CROs). How could this accelerate research and bring novel therapies to patients faster? Find out...

Advertisement

Covance, Pathoquest to Provide NGS Biosafety Assessments

November 5, 2013 10:34 am | News | Comments

Covance Inc. and Pathoquest have announced a collaboration that will provide next-generation sequencing (NGS) based biosafety assessments.  How will this solve the problem of viral contamination of biologics during development? Find out...

Cel-Sci Seeks $50M in Damages From Former CRO

October 31, 2013 12:19 pm | News | Comments

Cel-Sci Corporation has initiated an arbitration claim against inVentiv Clinical LLC, the clinical research organization that was initially retained to conduct the phase 3 clinical trial of the company's lead investigational drug. What are the reasons for this claim? Find out... 

Molecular Imaging Launches New Imaging Center

October 23, 2013 2:41 pm | News | Comments

Molecular Imaging Inc. (MII) has finalized an agreement to run a new state-of-the-art preclinical imaging center at the Sanford Consortium for Regenerative Medicine (Sanford Consortium) in La Jolla, California. So will the center serve Sanford Consortium investigators, non-affiliated stem cell researchers, other academic scientists and the pharmaceutical discovery industry? Find out...

Why Aesica Sees “Huge” Potential in Inhalation

October 17, 2013 3:55 pm | by Andrew S. Wiecek, Editor | Articles | Comments

Why is the global contract development and manufacturing organization (CDMO) targeting the inhalation development and manufacturing market with plans for a new technical center at its Nottingham, U.K. location? And what advances in inhalation technology has the company incorporated into their services? Find out…

Crown Bioscience, Xstrahl Enter Collaboration for Oncology Research Services

October 15, 2013 2:28 pm | News | Comments

Crown Bioscience Inc., a drug discovery and development service company, has entered into a collaboration with Xstrahl Ltd., a designer and manufacturer of X-Ray solutions for radiation biology research. How will this improve the company's contract research oncology models? Find out...

Yale and Genae Sign Collaborative Agreement

October 11, 2013 1:09 pm | News | Comments

Yale Cardiovascular Research Group and Genae Associates NV have signed a collaboration and co-marketing agreement. YCRG and Genae will formalize various platforms to facilitate collaboration. So what will the collaboration include? Find out...

PRA and RPS Merger Completed

September 26, 2013 3:52 pm | News | Comments

PRA International, a leading clinical research organization, today announced the completion of its merger with Research Pharmaceutical Services (“RPS”) and the closing of the acquisition by KKR. The combination of PRA and RPS creates the fourth largest contract research organization (CRO). Read more...

ClinicalRM Wins NIH Contract

September 13, 2013 1:18 pm | News | Comments

Clinical Research Management Inc. was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) to provide a broad spectrum of services for the design and conduct of clinical trials and clinical studies focused on the screening, diagnosis, treatment, prevention and control of sexually transmitted infections. 

PPD Makes Innovative Business Technology Users List

September 12, 2013 12:52 pm | News | Comments

Pharmaceutical Product Development LLC (PPD) has been named to the annual InformationWeek 500 ranking of the most innovative business technology users in the United States for the fourth consecutive year for applying technology resources to drive value for biopharmaceutical industry clients.

Global CRO Now Offers Clinical Research Monitor Credential

September 12, 2013 9:30 am | News | Comments

INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process for delivering reliable results, announced it is the first global CRO to implement the Clinical Research Monitor Accreditation program, an internationally recognized standard for competence in clinical research monitoring offered through the International Academy of Clinical Research (IAoCR).

Merck, Quintiles Sign Collaboration

May 17, 2013 11:42 am | News | Comments

In a novel approach to clinical development that is founded on a shared commitment to cost-disciplined science, Merck and Quintiles have signed a collaboration intended to optimize productivity in the design and execution of studies with a focus on quality, speed, and efficiency.

Top Sponsors Rated by Investigative Sites

March 4, 2013 10:31 am | News | Comments

Biogen Idec, Forest Laboratories, and Bayer claimed the top three spots in the 2013 Global Investigative Site Relationship survey. More than 2,000 global investigative sites rated the best biopharmaceutical companies to work for across 36 relationship attributes.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading